As a strategic planning and marketing consultant, Ellynn Decter Szoke develops strategic and tactical plans to influence stakeholder audiences and impact revenue growth and profitability.
She began her career at Johnson and Johnson Baby Products Company, held positions in project management for emerging companies and was a business development executive for a media company. She built her own marketing and communications firm and then was hired by a client to build a marketing and communications department, serving as Vice President.
Ellynn consulted for multiple high-growth organizations and in 2011 became Chief Marketing Officer for a first-to-market healthcare technology company. She now focuses on market shaping and commercialization for early stage companies or companies seeking to redefine their value proposition. Her clients spanned industry verticals: pharmaceutical, medical devices/diagnostics, clinical labs, tech, CPG, insurance, business services, consumer electronics and automotive.
The diversity of her expertise gives Ellynn a unique perspective, enabling her to identify high potential business opportunities by market segment and target audience, developing outcomes-focused business strategies aligned with corporate objectives and key industry trends. This includes defining the business or project scope, developing differentiated value propositions, analyzing competitive intelligence, and integrating core go-to-market strategies. With an intuitive understanding of the challenges businesses face and an intensified emphasis on revenue-focused engagement, Ellynn builds scalable, integrated cross-channel plans to drive impact and deliver results. Core to every initiative is performance measurement and analytics designed to evaluate predictive behavior, identify target audience trends, and provide business intelligence and insights.
Ellynn Decter Szoke is a member of the CMO Council, BioNJ, the Healthcare Businesswoman's Association, the Health Institute of NJ, and is a co-founder of The New Jersey Rare Disease Alliance, a multi-stakeholder organization focused on raising awareness and improving the lives of rare disease patients. She currently serves on the Board of the Ruth Gottscho Kidney Foundation and was formerly on the Board of the Cluster Headache Support Group.
A speaker at industry conferences, Ellynn has presented both from the perspective of industry and as a patient advocate. She attended the Harvard Business School Growth Innovation Workshop led by Clayton Christensen, the leading authority on disruptive innovation. In 2003 Ellynn was awarded the Healthcare Businesswomen's Association HBA Rising Star Award. While at Genigraphics, a Syracuse, NY-based media company, she was recognized both for "Superior Performance - #1 in Total Annual New Business Revenue" and for "Superior Performance - #3 in Total Annual Revenue." The awards were presented annually at a national sales meeting for over 500 business development executives.